Using living cells to treat – and sometimes even cure – cancer is one of the most dramatic advances in modern medicine. Patients with hematologic malignancies have been successfully treated with cell therapies. However, these profound results have not yet been achieved in patients with solid tumors, representing approximately 90% of all cancers. At Lyell, our goal is to change that. We are a clinical-stage T-cell reprogramming company advancing a diverse pipeline of cell therapies for solid tumors based on our innovative technologies. We were founded by cell therapy pioneers whose decades of research elevated the broader understanding of T-cell biology and its interaction with cancer. In our quest to defeat solid tumors, we have built a fully integrated company capable of discovering new technologies, translating science into therapies, manufacturing cell therapy products, and clinically evaluating them in patients. Our culture is based on Science, Respect, Collaboration, and Courage and reflects who we are, the environment we create, and our mission's urgency.
View Top Employees from Lyell ImmunopharmaWebsite | http://www.lyell.com |
Ticker | LYEL |
Revenue | $8.8 million |
Employees | 311 (311 on RocketReach) |
Founded | 2018 |
Address | 201 Haskins Way, South San Francisco, California 94080, US |
Phone | (650) 695-0677 |
Technologies |
JavaScript,
HTML,
reCAPTCHA
+78 more
(view full list)
|
Industry | Biotechnology Research, Drug Manufacturing & Research, Pharmaceuticals, Healthcare |
Keywords | Cancer Treatment, Cell Therapies, Hematologic Malignancies |
Competitors | Allogene Therapeutics, CARsgen Therapeutics, Celularity Inc., TCR² Therapeutics Inc. |
SIC | SIC Code 87 Companies, SIC Code 283 Companies, SIC Code 873 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 541 Companies, NAICS Code 54 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Lyell Immunopharma employee's phone or email?
The Lyell Immunopharma annual revenue was $8.8 million in 2024.
Richard Goold is the CIO of Lyell Immunopharma.
311 people are employed at Lyell Immunopharma.
Lyell Immunopharma is based in South San Francisco, California.
The NAICS codes for Lyell Immunopharma are [32541, 541, 54, 32, 325, 3254].
The SIC codes for Lyell Immunopharma are [87, 283, 873, 28].